376-390 of 831
Diving into the Genetic Pathway: A Look at the STING Pathway & Brain Cancer
NeuroFrontiersDiving into the Genetic Pathway: A Look at the STING Pathway & Brain Cancer
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Sean Lawler, PhD
Exploring New Research on Melanoma Brain Metastases
NeuroFrontiersExploring New Research on Melanoma Brain Metastases
Benjamin Izar, MD
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Uncovering the State of Antidepressants: Updates from Psych Congress
Psych Congress Action CenterUncovering the State of Antidepressants: Updates from Psych Congress
Exploring Marijuana Use in Psychopharmacology: A Look Ahead at the Psych Congress
Psych Congress Action CenterExploring Marijuana Use in Psychopharmacology: A Look Ahead at the Psych Congress
Discovering Face Blindness: An Expert’s Perspective on Prosopagnosia
NeuroFrontiersDiscovering Face Blindness: An Expert’s Perspective on Prosopagnosia
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Jason Barton, MD, PhD, FRCP(C)
Advances in Temporal Lobe Epilepsy Research
NeuroFrontiersAdvances in Temporal Lobe Epilepsy Research
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Sanjay Kumar, PhD
- advertisement
Exploring Alzheimer’s Disease Risk Loci: 75 & Counting
NeuroFrontiersExploring Alzheimer’s Disease Risk Loci: 75 & Counting
Jerome Lisk, MD, MBA, M.S., FAAN
Mark Mintz, MD
Clinical Considerations for the Treatment of Schizophrenia
NeuroFrontiersClinical Considerations for the Treatment of Schizophrenia
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Craig Chepke, MD, FAPA
Investigating the Link Between Hypertension Medications & Dementia
NeuroFrontiersInvestigating the Link Between Hypertension Medications & Dementia
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Zachary Marcum, PharmD, PhD
B-Cell Therapy: When Is It Right for Our MS Patients?
NeuroFrontiersB-Cell Therapy: When Is It Right for Our MS Patients?
Charles Turck, PharmD, BCPS, BCCCP
Andrew Chan, MD
Alzheimer’s Disease: What’s The Latest Research?
NeuroFrontiersAlzheimer’s Disease: What’s The Latest Research?
Jerome Lisk, MD, MBA, M.S., FAAN
Peter Whitehouse, MD, PhD
Daniel George, MSc, PhD
- advertisement
Diving into the Debate Surrounding Aducanumab for Alzheimer’s
NeuroFrontiersDiving into the Debate Surrounding Aducanumab for Alzheimer’s
Jerome Lisk, MD, MBA, M.S., FAAN
Peter Whitehouse, MD, PhD
Investigating the Impact of Mobile Stroke Units
NeuroFrontiersInvestigating the Impact of Mobile Stroke Units
Investigating the Potential Link Between Epstein-Barr Virus & MS
NeuroFrontiersInvestigating the Potential Link Between Epstein-Barr Virus & MS
